|
|
| (5 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | {{pnc}}__NOTOC__ | | {{pnc}}__NOTOC__ |
| | | | |
| | + | {{ft|I}} |
| | *'''[[Antibody-dependent enhancement ]]''' | | *'''[[Antibody-dependent enhancement ]]''' |
| | *'''[[Herd immunity ]]''' | | *'''[[Herd immunity ]]''' |
| Zeile 10: |
Zeile 11: |
| | *'''[[T cell exhaustion ]]''' | | *'''[[T cell exhaustion ]]''' |
| | *'''[[NK cells ]]''' | | *'''[[NK cells ]]''' |
| | + | |
| | + | *'''[[MDSC myeloid-derived suppressor cells]] |
| | *'''[[Antiviral immune response ]]''' | | *'''[[Antiviral immune response ]]''' |
| | *'''[[Antiviral mediators ]]''' | | *'''[[Antiviral mediators ]]''' |
| Zeile 17: |
Zeile 20: |
| | *'''[[Eosinophils ]]''' | | *'''[[Eosinophils ]]''' |
| | *'''[[Microbiome ]]''' | | *'''[[Microbiome ]]''' |
| | + | *'''[[Pneumococcal synergism]]''' -new- |
| | *'''[[Bio-misc ]]''' ''on topic biology papers which cannot be indexed by title'' | | *'''[[Bio-misc ]]''' ''on topic biology papers which cannot be indexed by title'' |
| | *'''[[Hematology ]]''' | | *'''[[Hematology ]]''' |
| Zeile 22: |
Zeile 26: |
| | *'''[[Candidate_Compounds_Covid19 |Immunopharmacology ]]''' | | *'''[[Candidate_Compounds_Covid19 |Immunopharmacology ]]''' |
| | *'''[[Diagnosis_(Laboratory) |Clinical Laboratory Dx]]''' | | *'''[[Diagnosis_(Laboratory) |Clinical Laboratory Dx]]''' |
| − |
| |
| − | 012
| |
| − |
| |
| − |
| |
| − | {{tp|p=32656452|t=2020. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.|pdf=|usr=013}}
| |
| − | {{tp|p=32631771|t=2020. COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult.|pdf=|usr=013}}
| |
| − | {{tp|p=32598981|t=2020. Infections and Collapsing Glomerulopathy.|pdf=|usr=013}}
| |
| − | {{tp|p=32564928|t=2020. Host immune responses to influenza infection and vaccines: Lessons learned for all viral pandemic challenges.|pdf=|usr=013}}
| |
| − | {{tp|p=32653819|t=2020. The autopsy at the time of SARS-CoV-2: Protocol and lessons.|pdf=|usr=013}}
| |
| − | {{tp|p=32571869|t=2020. Kawasaki disease or Kawasaki syndrome?|pdf=|usr=013}}
| |
| − | {{tp|p=32489438|t=2020. Spectrum of histopathological findings in coronavirus disease-19, Middle East respiratory syndrome and severe acute respiratory syndrome.|pdf=|usr=013}}
| |
| − | {{tp|p=32565134|t=2020. The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.|pdf=|usr=013}}
| |
| − | {{tp|p=32533513|t=2020. Cytosolic DNA sensing through cGAS and STING is inactivated by gene mutations in pangolins.|pdf=|usr=013}}
| |
| − | {{tp|p=32405132|t=2020. Targeting the Linear Ubiquitin Assembly Complex to Modulate the Host Response and Improve Influenza A Virus Induced Lung Injury.|pdf=|usr=013}}
| |
| − | {{tp|p=32653765|t=2020. Immunosenescence exacerbates the COVID-19.|pdf=|usr=013}}
| |
| − | {{tp|p=32611485|t=2020. Molecular Alterations Prompted by SARS-CoV-2 Infection: Induction of Hyaluronan, Glycosaminoglycan and Mucopolysaccharide Metabolism.|pdf=|usr=013}}
| |
| − | {{tp|p=32651741|t=2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.|pdf=|usr=013}}
| |
| − | {{tp|p=32559654|t=2020. Hypoxia induced up-regulation of tissue factor is mediated through extracellular RNA activated Toll-like receptor 3-activated protein 1 signalling.|pdf=|usr=013}}
| |
| − | {{tp|p=32646445|t=2020. Isolation and characterization of WUPyV in polarized human airway epithelial cells.|pdf=|usr=013}}
| |
| − | {{tp|p=32618551|t=2020. Covid-19 and Kawasaki syndrome.|pdf=|usr=013}}
| |
| − | {{tp|p=32645325|t=2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.|pdf=|usr=013}}
| |
| − | {{tp|p=32645326|t=2020. Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.|pdf=|usr=013}}
| |
| − | {{tp|p=32649876|t=2020. Human Virus Transcriptional Regulators.|pdf=|usr=013}}
| |
| − | {{tp|p=32623480|t=2020. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.|pdf=|usr=013}}
| |
| − | {{tp|p=32623546|t=2020. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.|pdf=|usr=013}}
| |
| − | {{tp|p=32632255|t=2020. Pulmonary alveolar regeneration in adult COVID-19 patients.|pdf=|usr=013}}
| |
| − | {{tp|p=32612199|t=2020. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.|pdf=|usr=013}}
| |
| − | {{tp|p=32622823|t=2020. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.|pdf=|usr=013}}
| |
| − | {{tp|p=32622819|t=2020. Two immunocompromised patients with diffuse alveolar hemorrhage as a complication of severe COVID-19.|pdf=|usr=013}}
| |
| − | {{tp|p=32118646|t=2020. Voice from China: nomenclature of the novel coronavirus and related diseases.|pdf=|usr=013}}
| |
| − | {{tp|p=32118645|t=2020. Single-cell RNA sequencing data suggest a role for angiotensin-converting enzyme 2 in kidney impairment in patients infected with 2019-novel coronavirus.|pdf=|usr=013}}
| |
| − | {{tp|p=32653658|t=2020. Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery.|pdf=|usr=013}}
| |
| − | {{tp|p=32533338|t=2020. A 9-year-old girl with Kawasaki disease and pulmonary nodules.|pdf=|usr=013}}
| |
| − | {{tp|p=32418043|t=2020. Experience with Cidofovir as an adjunctive therapy in a patient of adenovirus-induced macrophage activation syndrome in systemic arthritis.|pdf=|usr=013}}
| |
| − | {{tp|p=32513224|t=2020. Serum and fecal profiles of aromatic microbial metabolites reflect gut microbiota disruption in critically ill patients: a prospective observational pilot study.|pdf=|usr=013}}
| |
| − | {{tp|p=32541570|t=2020. Bronchiolitis and Potential Pathophysiological Implications in Coronavirus Disease 2019 ARDS Patients With Near-Normal Respiratory Compliance.|pdf=|usr=013}}
| |
| − | {{tp|p=32642354|t=2020. Do COVID-19 and SARS Gene Complexities and Variations Help Overcome the Knowledge Gap?|pdf=|usr=013}}
| |
| − | {{tp|p=32428465|t=2020. Pandemics and the great evolutionary mismatch.|pdf=|usr=013}}
| |
| − | {{tp|p=32563779|t=2020. Protective and pathogenic roles for mast cells during viral infections.|pdf=|usr=013}}
| |
| − | {{tp|p=32484440|t=2020. Shear stress activates ADAM10 sheddase to regulate Notch1 via the Piezo1 force sensor in endothelial cells.|pdf=|usr=013}}
| |
| − | {{tp|p=32617121|t=2020. Myocardial and Microvascular Injury Due to Coronavirus Disease 2019.|pdf=|usr=013}}
| |
| − | {{tp|p=24935083|t=2015. Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party.|pdf=|usr=013}}
| |
| − | {{tp|p=23452147|t=2013. Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins.|pdf=|usr=013}}
| |
| − | {{tp|p=32641214|t=2020. SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle.|pdf=|usr=013}}
| |
| − | {{tp|p=32637365|t=2020. Participation of the IL-10RB Related Cytokines, IL-22 and IFN-lambda in Defense of the Airway Mucosal Barrier.|pdf=|usr=013}}
| |
| − | {{tp|p=32655580|t=2020. Human Sialome and Coronavirus Disease-2019 (COVID-19) Pandemic: An Understated Correlation?|pdf=|usr=013}}
| |
| − | {{tp|p=32655579|t=2020. Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis.|pdf=|usr=013}}
| |
| − | {{tp|p=32612617|t=2020. The COVID-19 Cytokine Storm; What We Know So Far.|pdf=|usr=013}}
| |
| − | {{tp|p=32582219|t=2020. IL-22 Plays a Critical Role in Maintaining Epithelial Integrity During Pulmonary Infection.|pdf=|usr=013}}
| |
| − | {{tp|p=32574256|t=2020. Pangolins Lack IFIH1/MDA5, a Cytoplasmic RNA Sensor That Initiates Innate Immune Defense Upon Coronavirus Infection.|pdf=|usr=013}}
| |
| − | {{tp|p=32626680|t=2020. Leucocyte Subsets Effectively Predict the Clinical Outcome of Patients With COVID-19 Pneumonia: A Retrospective Case-Control Study.|pdf=|usr=013}}
| |
| − | {{tp|p=32392463|t=2020. Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection.|pdf=|usr=013}}
| |
| − | {{tp|p=32294404|t=2020. Something Else to Stress about: Perinatal Stress Attenuates CD8(+) T Cell Activity in Adults.|pdf=|usr=013}}
| |
| − | {{tp|p=32500198|t=2020. Corona deaths in Hamburg, Germany.|pdf=|usr=013}}
| |
| − | {{tp|p=32626922|t=2020. A dissection of SARSCoV2 with clinical implications (Review).|pdf=|usr=013}}
| |
| − | {{tp|p=32466119|t=2020. Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.|pdf=|usr=013}}
| |
| − | {{tp|p=32365944|t=2020. SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.|pdf=|usr=013}}
| |
| − | {{tp|p=32340172|t=2020. Glycyrrhizin Inhibits PEDV Infection and Proinflammatory Cytokine Secretion via the HMGB1/TLR4-MAPK p38 Pathway.|pdf=|usr=013}}
| |
| − | {{tp|p=32488343|t=2020. Coronavirus disease 2019 as a particular sepsis: a 2-week follow-up of standard immunological parameters in critically ill patients.|pdf=|usr=013}}
| |
| − | {{tp|p=32385629|t=2020. From the quarantine diary of an emergency physician: the coronavirus and the dysautonomic storm.|pdf=|usr=013}}
| |
| − | {{tp|p=17340620|t=2007. Angiotensin converting enzyme 2 is primarily epithelial and is developmentally regulated in the mouse lung.|pdf=|usr=013}}
| |
| − | {{tp|p=28063205|t=2017. Pathogenetic determinants in Kawasaki disease: the haematological point of view.|pdf=|usr=013}}
| |
| − | {{tp|p=30146782|t=2019. Modulation of the immune response by Middle East respiratory syndrome coronavirus.|pdf=|usr=013}}
| |
| − | {{tp|p=32648027|t=2020. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.|pdf=|usr=013}}
| |
| − | {{tp|p=32623351|t=2020. Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates.|pdf=|usr=013}}
| |
| − | {{tp|p=16752365|t=2006. Coronavirus phylogeny based on 2D graphical representation of DNA sequence.|pdf=|usr=013}}
| |
| − | {{tp|p=32006540|t=2020. Genetic diversity and potential recombination between ferret coronaviruses from European and American lineages.|pdf=|usr=013}}
| |
| − | {{tp|p=32142930|t=2020. Insights into the cross-species evolution of 2019 novel coronavirus.|pdf=|usr=013}}
| |
| − | {{tp|p=26287378|t=2016. Viral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis.|pdf=|usr=013}}
| |
| − | {{tp|p=24760654|t=2014. Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease.|pdf=|usr=013}}
| |
| − | {{tp|p=32585239|t=2020. Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features.|pdf=|usr=013}}
| |
| − | {{tp|p=32441751|t=2020. Pediatric Coronavirus Disease-2019-Associated Multisystem Inflammatory Syndrome.|pdf=|usr=013}}
| |
| − | {{tp|p=32582339|t=2020. Variation of 2019 novel coronavirus complete genomes recorded in the 1(st) month of outbreak: Implication for mutation.|pdf=|usr=013}}
| |
| − | {{tp|p=32188728|t=2020. Structure-Guided Mutagenesis Alters Deubiquitinating Activity and Attenuates Pathogenesis of a Murine Coronavirus.|pdf=|usr=013}}
| |
| − | {{tp|p=26269185|t=2015. Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination.|pdf=|usr=013}}
| |
| − | {{tp|p=24478444|t=2014. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity.|pdf=|usr=013}}
| |
| − | {{tp|p=16940539|t=2006. Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein.|pdf=|usr=013}}
| |
| − | {{tp|p=32432657|t=2020. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults.|pdf=|usr=013}}
| |
| − | {{tp|p=32437764|t=2020. Visualization of putative coronavirus in kidney.|pdf=|usr=013}}
| |
| − | {{tp|p=32505464|t=2020. Am I a coronavirus?|pdf=|usr=013}}
| |
| − | {{tp|p=32653518|t=2020. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.|pdf=|usr=013}}
| |
| − | {{tp|p=32498008|t=2020. Is the gingival sulcus a potential niche for SARS-Corona virus-2?|pdf=|usr=013}}
| |
| − | {{tp|p=32652428|t=2020. Coronavirus disease 2019 (COVID 19) and Malaria: Have anti glycoprotein antibodies a role?|pdf=|usr=013}}
| |
| − | {{tp|p=32634734|t=2020. Hypoxemia in COVID-19 patients: An hypothesis.|pdf=|usr=013}}
| |
| − | {{tp|p=32653475|t=2020. Does the hygiene hypothesis apply to COVID-19 susceptibility?|pdf=|usr=013}}
| |
| − | {{tp|p=32656314|t=2020. COVID-19-A theory of autoimmunity to ACE-2.|pdf=|usr=013}}
| |
| − | {{tp|p=25077179|t=2014. Kawasaki disease patients homozygous for the rs12252-C variant of interferon-induced transmembrane protein-3 are significantly more likely to develop coronary artery lesions.|pdf=|usr=013}}
| |
| − | {{tp|p=32598829|t=2020. Childhood Multisystem Inflammatory Syndrome - A New Challenge in the Pandemic.|pdf=|usr=013}}
| |
| − | {{tp|p=32461612|t=2020. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation.|pdf=|usr=013}}
| |
| − | {{tp|p=32555182|t=2020. Cryo-EM structures of HKU2 and SADS-CoV spike glycoproteins provide insights into coronavirus evolution.|pdf=|usr=013}}
| |
| − | {{tp|p=32591759|t=2020. Caught by NETs.|pdf=|usr=013}}
| |
| − | {{tp|p=32591758|t=2020. Transient IgA, steady IgG?|pdf=|usr=013}}
| |
| − | {{tp|p=32533112|t=2020. Neutralizing antibodies in convalescent patients.|pdf=|usr=013}}
| |
| − | {{tp|p=32651568|t=2020. T cell renaissance in COVID-19.|pdf=|usr=013}}
| |
| − | {{tp|p=32533130|t=2020. Epigenetic and epitranscriptomic regulation of viral replication.|pdf=|usr=013}}
| |
| − | {{tp|p=32561857|t=2020. Coronavirus replication factories.|pdf=|usr=013}}
| |
| − | {{tp|p=32287794|t=2020. Wuhan-like virus discovered seven years ago.|pdf=|usr=013}}
| |
| − | {{tp|p=31863580|t=2020. A nucleobase-binding pocket in a viral RNA-dependent RNA polymerase contributes to elongation complex stability.|pdf=|usr=013}}
| |
| − | {{tp|p=30070073|t=2018. Is an infectious trigger always required for primary hemophagocytic lymphohistiocytosis? Lessons from in utero and neonatal disease.|pdf=|usr=013}}
| |
| − | {{tp|p=28950425|t=2018. Pulmonary presentation of Kawasaki disease-A diagnostic challenge.|pdf=|usr=013}}
| |
| − | {{tp|p=22022266|t=2011. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex.|pdf=|usr=013}}
| |
| − | {{tp|p=32620366|t=2020. COVID-19 and the male susceptibility: the role of ACE2, TMPRSS2 and the androgen receptor.|pdf=|usr=013}}
| |
| − | {{tp|p=32611518|t=2020. COVID-19: Role of neutrophil extracellular traps in acute lung injury.|pdf=|usr=013}}
| |
| − | {{tp|p=32650970|t=2020. Autopsy findings from the first known death from Severe Acute Respiratory Syndrome SARS-CoV-2 in Spain.|pdf=|usr=013}}
| |
| − | {{tp|p=32650969|t=2020. The first COVID-19 autopsy in Spain performed during the early stages of the pandemic.|pdf=|usr=013}}
| |
| − | {{tp|p=32434680|t=2020. AID in Antibody Diversification: There and Back Again.|pdf=|usr=013}}
| |
| − | {{tp|p=32651761|t=2020. Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental animals: a systematic review.|pdf=|usr=013}}
| |
| − | {{tp|p=28738245|t=2017. Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication.|pdf=|usr=013}}
| |
| − | {{tp|p=18045721|t=2008. SARS coronavirus accessory proteins.|pdf=|usr=013}}
| |
| − | {{tp|p=32456011|t=2020. The Role of Extracellular Vesicles as Allies of HIV, HCV and SARS Viruses.|pdf=|usr=013}}
| |
| − | {{tp|p=32331321|t=2020. Broadly Neutralizing Bovine Antibodies: Highly Effective New Tools against Evasive Pathogens?|pdf=|usr=013}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32656452|t=2020. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.|pdf=|usr=014}}
| |
| − | {{tp|p=32712145|t=2020. Multisystem inflammatory syndrome with particular cutaneous lesions related to COVID 19 in a young adult.|pdf=|usr=014}}
| |
| − | {{tp|p=32659225|t=2020. The role of a cytokine storm in severe COVID-19 disease in pregnancy.|pdf=|usr=014}}
| |
| − | {{tp|p=32701539|t=2020. HLA-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32659620|t=2020. Cytologic and molecular correlates of SARS-CoV-2 infection of the nasopharynx.|pdf=|usr=014}}
| |
| − | {{tp|p=32653819|t=2020. The autopsy at the time of SARS-CoV-2: Protocol and lessons.|pdf=|usr=014}}
| |
| − | {{tp|p=32676824|t=2020. Respiratory mechanics and gas exchanges in the early course of COVID-19 ARDS: a hypothesis-generating study.|pdf=|usr=014}}
| |
| − | {{tp|p=32708525|t=2020. From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry.|pdf=|usr=014}}
| |
| − | {{tp|p=32669265|t=2020. Discovery of M Protease inhibitors encoded by SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32708430|t=2020. Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm.|pdf=|usr=014}}
| |
| − | {{tp|p=32653765|t=2020. Immunosenescence exacerbates the COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32651741|t=2020. Gene expression pattern differences in primary human pulmonary epithelial cells infected with MERS-CoV or SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32717432|t=2020. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.|pdf=|usr=014}}
| |
| − | {{tp|p=32685484|t=2020. Identification of COVID-19 Infection-Related Human Genes Based on a Random Walk Model in a Virus-Human Protein Interaction Network.|pdf=|usr=014}}
| |
| − | {{tp|p=32664932|t=2020. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?|pdf=|usr=014}}
| |
| − | {{tp|p=32664879|t=2020. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis.|pdf=|usr=014}}
| |
| − | {{tp|p=32665075|t=2020. Oral ulceration as presenting feature of paediatric inflammatory multisystem syndrome associated with COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32708264|t=2020. Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32645325|t=2020. The Global Phosphorylation Landscape of SARS-CoV-2 Infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32697970|t=2020. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.|pdf=|usr=014}}
| |
| − | {{tp|p=32697968|t=2020. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus.|pdf=|usr=014}}
| |
| − | {{tp|p=32673567|t=2020. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32690996|t=2020. COVID-19 infection: mitohormetic concept of immune response.|pdf=|usr=014}}
| |
| − | {{tp|p=32697943|t=2020. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis.|pdf=|usr=014}}
| |
| − | {{tp|p=32612152|t=2020. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32623480|t=2020. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.|pdf=|usr=014}}
| |
| − | {{tp|p=32712910|t=2020. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.|pdf=|usr=014}}
| |
| − | {{tp|p=32623546|t=2020. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus.|pdf=|usr=014}}
| |
| − | {{tp|p=32668215|t=2020. Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32632255|t=2020. Pulmonary alveolar regeneration in adult COVID-19 patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32612199|t=2020. Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32673562|t=2020. RNA-GPS Predicts SARS-CoV-2 RNA Residency to Host Mitochondria and Nucleolus.|pdf=|usr=014}}
| |
| − | {{tp|p=32619549|t=2020. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32660065|t=2020. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.|pdf=|usr=014}}
| |
| − | {{tp|p=32635598|t=2020. Canonical and Noncanonical Autophagy as Potential Targets for COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32707842|t=2020. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes.|pdf=|usr=014}}
| |
| − | {{tp|p=32622823|t=2020. Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.|pdf=|usr=014}}
| |
| − | {{tp|p=32707182|t=2020. Novel Temperature Trajectory Subphenotypes in COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32622819|t=2020. Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.|pdf=|usr=014}}
| |
| − | {{tp|p=32630212|t=2020. Multi-System Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Review of Clinical Presentation, Hypothetical Pathogenesis, and Proposed Management.|pdf=|usr=014}}
| |
| − | {{tp|p=32700055|t=2020. The extended autonomic system, dyshomeostasis, and COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32671502|t=2020. Is 'happy hypoxia' in COVID-19 a disorder of autonomic interoception? A hypothesis.|pdf=|usr=014}}
| |
| − | {{tp|p=32661775|t=2020. Testing cardiovascular autonomic function in the COVID-19 era: lessons from Bologna's Autonomic Unit.|pdf=|usr=014}}
| |
| − | {{tp|p=32673668|t=2020. Insights into pediatric multi-system inflammatory syndrome and COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32683814|t=2020. Can we get a clue for the etiology of Kawasaki disease in the COVID-19 pandemic?|pdf=|usr=014}}
| |
| − | {{tp|p=32664709|t=2020. Immunopathogenesis of COVID-19 and early immunomodulators.|pdf=|usr=014}}
| |
| − | {{tp|p=32712394|t=2020. Letter to the Editor: Lessons from COVID-19, ACE2 and intestinal inflammation - could a virus trigger chronic intestinal inflammation?|pdf=|usr=014}}
| |
| − | {{tp|p=32659373|t=2020. Long-term infection of SARS-CoV-2 changed the body's immune status.|pdf=|usr=014}}
| |
| − | {{tp|p=32653662|t=2020. Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32653658|t=2020. Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery.|pdf=|usr=014}}
| |
| − | {{tp|p=32717416|t=2020. Evolution of viral quasispecies during SARS-CoV-2 infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32711057|t=2020. Viable SARS-CoV-2 in various specimens from COVID-19 patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32688067|t=2020. Body temperature and host species preferences of SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32658736|t=2020. Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans.|pdf=|usr=014}}
| |
| − | {{tp|p=32709253|t=2020. Response to "Body temperature correlates with mortality in COVID-19 patients".|pdf=|usr=014}}
| |
| − | {{tp|p=32698857|t=2020. Could the severity of COVID-19 be increased by low gastric acidity?|pdf=|usr=014}}
| |
| − | {{tp|p=32690058|t=2020. Detection of IgG antibody during the follow-up in patients with COVID-19 infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32711241|t=2020. Coronavirus infection and immune system: An insight of COVID-19 in cancer patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32685628|t=2020. Haematological and immunological data of Chinese children infected with coronavirus disease 2019.|pdf=|usr=014}}
| |
| − | {{tp|p=32707212|t=2020. Lymphocyte subsets with the lowest decline at baselineand the slow lowest rise during recovery in COVID-19 critical illnesspatients with diabetes mellitus.|pdf=|usr=014}}
| |
| − | {{tp|p=32665025|t=2020. The spectrum of pathological findings in coronavirus disease (COVID-19) and the pathogenesis of SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32699547|t=2020. Kawasaki disease in siblings and a review of drug treatment.|pdf=|usr=014}}
| |
| − | {{tp|p=32711256|t=2020. Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis.|pdf=|usr=014}}
| |
| − | {{tp|p=32711254|t=2020. Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity.|pdf=|usr=014}}
| |
| − | {{tp|p=32707445|t=2020. Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections.|pdf=|usr=014}}
| |
| − | {{tp|p=32717182|t=2020. Lessons for COVID-19 Immunity from Other Coronavirus Infections.|pdf=|usr=014}}
| |
| − | {{tp|p=32712315|t=2020. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors.|pdf=|usr=014}}
| |
| − | {{tp|p=32707288|t=2020. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32668462|t=2020. COVID-19: An Immunopathologic Assault.|pdf=|usr=014}}
| |
| − | {{tp|p=32709193|t=2020. Lung Injury in COVID-19-An Emerging Hypothesis.|pdf=|usr=014}}
| |
| − | {{tp|p=32673476|t=2020. Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism.|pdf=|usr=014}}
| |
| − | {{tp|p=32672403|t=2020. microRNAs as new possible actors in gender disparities of Covid-19 pandemic.|pdf=|usr=014}}
| |
| − | {{tp|p=32662161|t=2020. Covid-19, ACE2, and the kidney.|pdf=|usr=014}}
| |
| − | {{tp|p=32681166|t=2020. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.|pdf=|usr=014}}
| |
| − | {{tp|p=32666092|t=2020. SARS-CoV-2 Antibody Responses Do Not Predict COVID-19 Disease Severity.|pdf=|usr=014}}
| |
| − | {{tp|p=32662111|t=2020. COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes.|pdf=|usr=014}}
| |
| − | {{tp|p=32706609|t=2020. Inducible Epithelial Resistance Against Coronavirus Pneumonia in Mice.|pdf=|usr=014}}
| |
| − | {{tp|p=32663409|t=2020. Single-cell RNA Expression Profiling of ACE2, The Receptor of SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32662396|t=2020. Temporal Change of SARS-CoV-2 in Clinical Specimens of COVID-19 Pneumonia Patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32705809|t=2020. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyperinflammation in COVID-19. Version 1.|pdf=|usr=014}}
| |
| − | {{tp|p=32716641|t=2020. Coronavirus Optimization Algorithm: A Bioinspired Metaheuristic Based on the COVID-19 Propagation Model.|pdf=|usr=014}}
| |
| − | {{tp|p=32686774|t=2020. Multiple sclerosis and COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32654296|t=2020. A Tale of (Glycogen Synthase Kinase) Three: Lithium, The Kidney and Coronavirus Disease 19.|pdf=|usr=014}}
| |
| − | {{tp|p=32679621|t=2020. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32678953|t=2020. Clinical characteristics, management and outcome of Covid-19-associated immune thrombocytopenia. A French multicenter series.|pdf=|usr=014}}
| |
| − | {{tp|p=32678950|t=2020. Single-cell oxygen saturation imaging shows that gas exchange by red blood cells is not impaired in COVID-19 patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32663362|t=2020. ACE2, the Receptor that Enables the Infection by SARS-CoV-2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators.|pdf=|usr=014}}
| |
| − | {{tp|p=32654514|t=2020. Cardiac Arrest Risk During Acute Infections: Systemic Inflammation Directly Prolongs QTc Interval via Cytokine-mediated Effects on Potassium Channel Expression.|pdf=|usr=014}}
| |
| − | {{tp|p=32689809|t=2020. Unexpected Features of Cardiac Pathology in COVID-19 Infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32706417|t=2020. Characteristics and roles of SARS-CoV-2 specific antibodies in patients with different severities of COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32717055|t=2020. Diagnosing SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): Focus on the Gastrointestinal Tract and the Myocardium.|pdf=|usr=014}}
| |
| − | {{tp|p=32710613|t=2020. Multi-Inflammatory Syndrome in Children related to SARS-CoV-2 in Spain.|pdf=|usr=014}}
| |
| − | {{tp|p=32672790|t=2020. Excess soluble fms-like tyrosine kinase 1 correlates with endothelial dysfunction and organ failure in critically ill COVID-19 patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32667973|t=2020. SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters.|pdf=|usr=014}}
| |
| − | {{tp|p=32663256|t=2020. Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity.|pdf=|usr=014}}
| |
| − | {{tp|p=32694169|t=2020. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?|pdf=|usr=014}}
| |
| − | {{tp|p=32713339|t=2020. Viral Evolution will Automatically Resolve COVID-19 Pandemic.|pdf=|usr=014}}
| |
| − | {{tp|p=32660402|t=2020. NPC1 as a Modulator of Disease Severity and Viral Entry of Sars-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32657802|t=2020. Severe acute respiratory syndrome coronavirus 2, original antigenic sin, and antibody-dependent enhancement: menage a trois.|pdf=|usr=014}}
| |
| − | {{tp|p=32675718|t=2020. Reflections on rheumatological aspects of COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32654350|t=2020. Decrease of non-classical and intermediate monocyte subsets in severe acute SARS-CoV-2 infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32662099|t=2020. Therapeutic dilemma in the repression of severe acute respiratory syndrome coronavirus-2 proteome.|pdf=|usr=014}}
| |
| − | {{tp|p=32657473|t=2020. TWIRLS, a knowledge-mining technology, suggests a possible mechanism for the pathological changes in the human host after coronavirus infection via ACE2.|pdf=|usr=014}}
| |
| − | {{tp|p=32652001|t=2020. Endocrine significance of SARS-CoV-2's reliance on ACE2.|pdf=|usr=014}}
| |
| − | {{tp|p=32686577|t=2020. Epigenetic mechanisms regulating COVID-19 infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32710612|t=2020. Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32643968|t=2020. Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress.|pdf=|usr=014}}
| |
| − | {{tp|p=32706090|t=2020. CXCL10 an important chemokine associated with cytokine storm in COVID-19 infected patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32692465|t=2020. COVID-19, Cilia, and Smell.|pdf=|usr=014}}
| |
| − | {{tp|p=32692408|t=2020. Third Trimester Placentas of SARS-CoV-2-Positive Women: Histomorphology, including Viral Immunohistochemistry and in Situ Hybridization.|pdf=|usr=014}}
| |
| − | {{tp|p=32678695|t=2020. Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development.|pdf=|usr=014}}
| |
| − | {{tp|p=32689852|t=2020. Immune Responses to the Novel Coronavirus-2: Friend or Foe?|pdf=|usr=014}}
| |
| − |
| |
| − | {{tp|p=32662421|t=2020. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?|pdf=|usr=014}}
| |
| − | {{tp|p=32665942|t=2020. Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia.|pdf=|usr=014}}
| |
| − | {{tp|p=32675207|t=2020. Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects.|pdf=|usr=014}}
| |
| − | {{tp|p=32675206|t=2020. Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue.|pdf=|usr=014}}
| |
| − | {{tp|p=32703822|t=2020. Abnormal carbon monoxide diffusion capacity in COVID-19 patients at time of hospital discharge.|pdf=|usr=014}}
| |
| − | {{tp|p=32714336|t=2020. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32676080|t=2020. "Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-gamma, IL-17A, and a Janus Kinase Inhibitor.|pdf=|usr=014}}
| |
| − | {{tp|p=32670298|t=2020. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.|pdf=|usr=014}}
| |
| − | {{tp|p=32695025|t=2020. Regulatory Cross Talk Between SARS-CoV-2 Receptor Binding and Replication Machinery in the Human Host.|pdf=|usr=014}}
| |
| − | {{tp|p=32676039|t=2020. COVID-19 Sepsis and Microcirculation Dysfunction.|pdf=|usr=014}}
| |
| − | {{tp|p=32658591|t=2020. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer.|pdf=|usr=014}}
| |
| − | {{tp|p=32682765|t=2020. Lipotoxicity and cytokine storm in severe acute pancreatitis and COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32668194|t=2020. Next-Generation Sequencing of T and B Cell Receptor Repertoires from COVID-19 Patients Showed Signatures Associated with Severity of Disease.|pdf=|usr=014}}
| |
| − | {{tp|p=32659267|t=2020. Intermittent fasting, a possible priming tool for host defense against SARS-CoV-2 infection: Crosstalk among calorie restriction, autophagy and immune response.|pdf=|usr=014}}
| |
| − | {{tp|p=32683337|t=2020. Pediatric Inflammatory Multisystem Syndrome Temporally Associated With COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32683336|t=2020. Hyperinflammatory Syndrome in Children Associated with COVID-19: Need for Awareness.|pdf=|usr=014}}
| |
| − | {{tp|p=32659347|t=2020. Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP.|pdf=|usr=014}}
| |
| − | {{tp|p=32708334|t=2020. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.|pdf=|usr=014}}
| |
| − | {{tp|p=32668803|t=2020. COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.|pdf=|usr=014}}
| |
| − | {{tp|p=32664543|t=2020. Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation.|pdf=|usr=014}}
| |
| − | {{tp|p=32681297|t=2020. Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?|pdf=|usr=014}}
| |
| − | {{tp|p=32666177|t=2020. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply.|pdf=|usr=014}}
| |
| − | {{tp|p=32695405|t=2020. COVID-19 and cryo-EM.|pdf=|usr=014}}
| |
| − | {{tp|p=32675285|t=2020. Intracellular autoactivation of TMPRSS11A, an airway epithelial transmembrane serine protease.|pdf=|usr=014}}
| |
| − | {{tp|p=32701511|t=2020. Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children.|pdf=|usr=014}}
| |
| − | {{tp|p=32708872|t=2020. Neutralizing Antibody Production in Asymptomatic and Mild COVID-19 Patients, in Comparison with Pneumonic COVID-19 Patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32674356|t=2020. Kurarinone Inhibits HCoV-OC43 Infection by Impairing the Virus-Induced Autophagic Flux in MRC-5 Human Lung Cells.|pdf=|usr=014}}
| |
| − | {{tp|p=32690544|t=2020. Genetic variations in the human severe acute respiratory syndrome coronavirus receptor ACE2 and serine protease TMPRSS2.|pdf=|usr=014}}
| |
| − | {{tp|p=32707511|t=2020. SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.|pdf=|usr=014}}
| |
| − | {{tp|p=32674001|t=2020. Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series.|pdf=|usr=014}}
| |
| − | {{tp|p=32652214|t=2020. Factors affecting stability and infectivity of SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32699345|t=2020. SARS-CoV-2 genomic variations associated with mortality rate of COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32675312|t=2020. ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32652168|t=2020. Oscillation of SARS CoV-2 RNA load in a cohort of children and adolescents with neuro-psychiatric disorders resident in a nursing home of Lombardy Region (Italy).|pdf=|usr=014}}
| |
| − | {{tp|p=32718895|t=2020. Immune response in COVID-19: A review.|pdf=|usr=014}}
| |
| − | {{tp|p=32707537|t=2020. Hazards of the cytokine storm and cytokine-targeted therapy in COVID-19 patients: A Review.|pdf=|usr=014}}
| |
| − | {{tp|p=32627759|t=2020. An Overview of the Genetic Variations of the SARS-CoV-2 Genomes Isolated in Southeast Asian Countries.|pdf=|usr=014}}
| |
| − | {{tp|p=32710986|t=2020. Mutations Strengthened SARS-CoV-2 Infectivity.|pdf=|usr=014}}
| |
| − | {{tp|p=32717229|t=2020. Epidemiological trends in Kawasaki disease during COVID-19 in Singapore.|pdf=|usr=014}}
| |
| − | {{tp|p=32661139|t=2020. Broad and differential animal ACE2 receptor usage by SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32706339|t=2020. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.|pdf=|usr=014}}
| |
| − | {{tp|p=32687484|t=2020. Severe immunosuppression and not a cytokine storm characterize COVID-19 infections.|pdf=|usr=014}}
| |
| − | {{tp|p=32659211|t=2020. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32682491|t=2020. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.|pdf=|usr=014}}
| |
| − | {{tp|p=32653054|t=2020. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.|pdf=|usr=014}}
| |
| − | {{tp|p=32653518|t=2020. Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges.|pdf=|usr=014}}
| |
| − | {{tp|p=32693241|t=2020. Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation.|pdf=|usr=014}}
| |
| − | {{tp|p=32687918|t=2020. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.|pdf=|usr=014}}
| |
| − | {{tp|p=32703818|t=2020. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.|pdf=|usr=014}}
| |
| − | {{tp|p=32694143|t=2020. Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32679426|t=2020. The <> able to explain the Th1 immune lockdown in severe COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32679424|t=2020. Natural protection of ocular surface from viral infections - A hypothesis.|pdf=|usr=014}}
| |
| − | {{tp|p=32673940|t=2020. EMMPRIN/BASIGIN as a biological modulator of oral cancer and COVID-19 interaction: Novel propositions.|pdf=|usr=014}}
| |
| − | {{tp|p=32683222|t=2020. The immunomodulatory effects of exercise against COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32679425|t=2020. The hypothesis that SARS-CoV-2 affects male reproductive ability by regulating autophagy.|pdf=|usr=014}}
| |
| − | {{tp|p=32664116|t=2020. Late histological findings in symptomatic COVID-19 patients: A case report.|pdf=|usr=014}}
| |
| − | {{tp|p=32670525|t=2020. Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure.|pdf=|usr=014}}
| |
| − | {{tp|p=32670517|t=2020. Kawasaki Disease as the Immune-Mediated Echo of a Viral Infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32653475|t=2020. Does the hygiene hypothesis apply to COVID-19 susceptibility?|pdf=|usr=014}}
| |
| − | {{tp|p=32710269|t=2020. Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32709887|t=2020. Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin.|pdf=|usr=014}}
| |
| − | {{tp|p=32709886|t=2020. Structural basis of RNA cap modification by SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32708840|t=2020. Genetic Diversity Among SARS-CoV2 Strains in South America may Impact Performance of Molecular Detection.|pdf=|usr=014}}
| |
| − | {{tp|p=32672799|t=2020. Eosinopenia and COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32680910|t=2020. Kidney Biopsy Findings in Patients with COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32675304|t=2020. Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32669323|t=2020. Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32660970|t=2020. COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.|pdf=|usr=014}}
| |
| − | {{tp|p=32651224|t=2020. Caution in Identifying Coronaviruses by Electron Microscopy.|pdf=|usr=014}}
| |
| − | {{tp|p=32700513|t=2020. Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall?|pdf=|usr=014}}
| |
| − | {{tp|p=32660959|t=2020. Is FURIN gene expression in salivary glands related to SARS-CoV-2 infectivity through saliva?|pdf=|usr=014}}
| |
| − | {{tp|p=32667280|t=2020. A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a.|pdf=|usr=014}}
| |
| − | {{tp|p=32699160|t=2020. COVID-19: Complement, Coagulation, and Collateral Damage.|pdf=|usr=014}}
| |
| − | {{tp|p=32696489|t=2020. Cytokine storm syndrome in coronavirus disease 2019: A narrative review.|pdf=|usr=014}}
| |
| − | {{tp|p=32716059|t=2020. Response to Comment on "Genetic Variants and Source of Introduction of SARS-CoV-2 in South America".|pdf=|usr=014}}
| |
| − | {{tp|p=32710647|t=2020. Antibody responses to SARS-CoV-2 in healthy individuals returning to Shenzhen.|pdf=|usr=014}}
| |
| − | {{tp|p=32706425|t=2020. The dynamic changes of serum IgM and IgG against SARS-CoV-2 in patients with COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32706420|t=2020. Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay.|pdf=|usr=014}}
| |
| − | {{tp|p=32706410|t=2020. SARS-CoV-2 Causes Kawasaki like Disease in children; Cases reported in Pakistan.|pdf=|usr=014}}
| |
| − | {{tp|p=32706407|t=2020. SARS-Cov-2 infection causes pulmonary shunt by vasodilatation.|pdf=|usr=014}}
| |
| − | {{tp|p=32681651|t=2020. COVID-19: What type of cytokine storm are we dealing with?|pdf=|usr=014}}
| |
| − | {{tp|p=32699095|t=2020. Evolutionary arms race between virus and host drives genetic diversity in bat SARS related coronavirus spike genes.|pdf=|usr=014}}
| |
| − | {{tp|p=32679087|t=2020. COVID-19: from rapid genome sequencing to fast decisions.|pdf=|usr=014}}
| |
| − | {{tp|p=32654359|t=2020. Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations.|pdf=|usr=014}}
| |
| − | {{tp|p=32687176|t=2020. Evidence for strong mutation bias towards, and selection against, U content in SARS-CoV-2: implications for vaccine design.|pdf=|usr=014}}
| |
| − | {{tp|p=32706959|t=2020. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32706954|t=2020. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32678534|t=2020. Pulmonary Vascular Pathology in Covid-19. Reply.|pdf=|usr=014}}
| |
| − | {{tp|p=32678533|t=2020. Pulmonary Vascular Pathology in Covid-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32678532|t=2020. Pulmonary Vascular Pathology in Covid-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32678531|t=2020. Pulmonary Vascular Pathology in Covid-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32719485|t=2020. Sampling the host response to SARS-CoV-2 in hospitals under siege.|pdf=|usr=014}}
| |
| − | {{tp|p=32661393|t=2020. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32704094|t=2020. LY6E impairs coronavirus fusion and confers immune control of viral disease.|pdf=|usr=014}}
| |
| − | {{tp|p=32669681|t=2020. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.|pdf=|usr=014}}
| |
| − | {{tp|p=32717743|t=2020. Longitudinal analyses reveal immunological misfiring in severe COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32668444|t=2020. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.|pdf=|usr=014}}
| |
| − | {{tp|p=32659783|t=2020. A perspective on potential antibody-dependent enhancement of SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32661414|t=2020. A race to determine what drives COVID-19 severity.|pdf=|usr=014}}
| |
| − | {{tp|p=32684080|t=2020. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.|pdf=|usr=014}}
| |
| − | {{tp|p=32659199|t=2020. COVID-19 Pulmonary and Olfactory Dysfunctions: Is the Chemokine CXCL10 the Common Denominator?|pdf=|usr=014}}
| |
| − | {{tp|p=32654247|t=2020. Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein.|pdf=|usr=014}}
| |
| − | {{tp|p=32672025|t=2020. Immunite cellulaire contre SARS-CoV-2 : substrat de l'immunite croisee entre coronavirus saisonniers et SARS-CoV-2 ?|pdf=|usr=014}}
| |
| − | {{tp|p=32686248|t=2020. Novel coronavirus SARS-CoV-2 (Covid-19) dynamics inside the human body.|pdf=|usr=014}}
| |
| − | {{tp|p=32671966|t=2020. Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.|pdf=|usr=014}}
| |
| − | {{tp|p=32656939|t=2020. Lessons from dermatology about inflammatory responses in Covid-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32668509|t=2020. Variabilidad genetica y epigenetica, y la pandemia de Covid-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32697854|t=2020. Interferon: the invisible link between COVID-19 and BCGitis female protection?|pdf=|usr=014}}
| |
| − | {{tp|p=32697367|t=2020. inverted question markAre Superantigens the Cause of Cytokine Storm and viral sepsis in Severe COVID-19? Observations and hypothesis.|pdf=|usr=014}}
| |
| − | {{tp|p=32680954|t=2020. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.|pdf=|usr=014}}
| |
| − | {{tp|p=32669287|t=2020. Comprehensive mapping of immune perturbations associated with severe COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32651212|t=2020. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.|pdf=|usr=014}}
| |
| − |
| |
| − | {{tp|p=32679910|t=2020. SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders.|pdf=|usr=014}}
| |
| − | {{tp|p=32678072|t=2020. Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020.|pdf=|usr=014}}
| |
| − | {{tp|p=32694615|t=2020. Comments to: A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression.|pdf=|usr=014}}
| |
| − | {{tp|p=32715628|t=2020. Can ACE2 expression explain SARS-CoV-2 infection of the respiratory epithelia in COVID-19?|pdf=|usr=014}}
| |
| − | {{tp|p=32715618|t=2020. The protein expression profile of ACE2 in human tissues.|pdf=|usr=014}}
| |
| − | {{tp|p=32669467|t=2020. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32694127|t=2020. COVID-19 and the Gut Microbiome: More than a Gut Feeling.|pdf=|usr=014}}
| |
| − | {{tp|p=32681106|t=2020. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.|pdf=|usr=014}}
| |
| − | {{tp|p=32665645|t=2020. SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses.|pdf=|usr=014}}
| |
| − | {{tp|p=32686754|t=2020. Antibody responses to SARS-CoV-2 short-lived.|pdf=|usr=014}}
| |
| − | {{tp|p=32686753|t=2020. Virus dissociated from inflammation in fatal COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32651570|t=2020. CRISPRing for host genes regulating SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32651569|t=2020. SARS-CoV-2 on the neural battleground.|pdf=|usr=014}}
| |
| − | {{tp|p=32651568|t=2020. T cell renaissance in COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32690876|t=2020. Can COVID-19 strike twice?|pdf=|usr=014}}
| |
| − | {{tp|p=32699357|t=2020. COVID-19 management in light of the circadian clock.|pdf=|usr=014}}
| |
| − | {{tp|p=32668692|t=2020. Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USA.|pdf=|usr=014}}
| |
| − | {{tp|p=32691391|t=2020. Chromosome X riddle in SARS-CoV-2 (COVID-19) - related lung pathology.|pdf=|usr=014}}
| |
| − | {{tp|p=32665786|t=2020. Lessons learned from the mechanisms of posttraumatic inflammation extrapolated to the inflammatory response in COVID-19: a review.|pdf=|usr=014}}
| |
| − | {{tp|p=32685291|t=2020. Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure.|pdf=|usr=014}}
| |
| − | {{tp|p=32659343|t=2020. Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report.|pdf=|usr=014}}
| |
| − | {{tp|p=32671793|t=2020. Single-cell analysis reveals bronchoalveolar epithelial dysfunction in COVID-19 patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32651900|t=2020. SARS-CoV-2 and Male Infertility: Possible Multifaceted Pathology.|pdf=|usr=014}}
| |
| − | {{tp|p=32611518|t=2020. COVID-19: Role of neutrophil extracellular traps in acute lung injury.|pdf=|usr=014}}
| |
| − | {{tp|p=32704472|t=2020. Hemophagocytic syndrome and COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32664949|t=2020. SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis.|pdf=|usr=014}}
| |
| − | {{tp|p=32704018|t=2020. Human SARS-CoV-2 has evolved to reduce CG dinucleotide in its open reading frames.|pdf=|usr=014}}
| |
| − | {{tp|p=32691370|t=2020. SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45(-) Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome.|pdf=|usr=014}}
| |
| − | {{tp|p=32702413|t=2020. Multisystem Inflammatory Syndrome in Children: Is There a Linkage to Kawasaki Disease?|pdf=|usr=014}}
| |
| − | {{tp|p=32653566|t=2020. Understanding The Complex Relationship Between Androgens and SARS-CoV2.|pdf=|usr=014}}
| |
| − | {{tp|p=32679691|t=2020. Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes.|pdf=|usr=014}}
| |
| − | {{tp|p=32666230|t=2020. Germany's first COVID-19 deceased: a 59-year-old man presenting with diffuse alveolar damage due to SARS-CoV-2 infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32699972|t=2020. Mild Cytokine Elevation, Moderate CD4(+) T Cell Response and Abundant Antibody Production in Children with COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32687861|t=2020. Phylogenetic and phylodynamic analyses of SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32674515|t=2020. Validation of Variant Assembly Using HAPHPIPE with Next-Generation Sequence Data from Viruses.|pdf=|usr=014}}
| |
| − | {{tp|p=32614178|t=2020. Pulmonary Edema in COVID19-A Neural Hypothesis.|pdf=|usr=012}}
| |
| − | {{tp|p=32638079|t=2020. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32628642|t=2020. Serum IgM against SARS-CoV-2 correlates with in-hospital mortality in severe/critical patients with COVID-19 in Wuhan, China.|pdf=|usr=012}}
| |
| − | {{tp|p=32650004|t=2020. Eicosanoids: the Overlooked Storm in COVID-19?|pdf=|usr=012}}
| |
| − | {{tp|p=32628931|t=2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.|pdf=|usr=012}}
| |
| − | {{tp|p=32639866|t=2020. DISEQUILIBRIUM BETWEEN THE CLASSIC RENIN-ANGIOTENSIN SYSTEM AND ITS OPPOSING ARM IN SARS-COV-2 RELATED LUNG INJURY.|pdf=|usr=012}}
| |
| − | {{tp|p=32622243|t=2020. Delving deep into the structural aspects of a furin cleavage site inserted into the spike protein of SARS-CoV-2: A structural biophysical perspective.|pdf=|usr=012}}
| |
| − | {{tp|p=32611313|t=2020. Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity.|pdf=|usr=012}}
| |
| − | {{tp|p=32629042|t=2020. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters.|pdf=|usr=012}}
| |
| − | {{tp|p=32646930|t=2020. Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1.|pdf=|usr=012}}
| |
| − | {{tp|p=32645391|t=2020. Correlation between cytokines and coagulation-related parameters in patients with coronavirus disease 2019 admitted to ICU.|pdf=|usr=012}}
| |
| − | {{tp|p=32646523|t=2020. Adrenomedullin in COVID-19 induced endotheliitis.|pdf=|usr=012}}
| |
| − | {{tp|p=32643351|t=2020. Successful sequencing of the first SARS-CoV-2 genomes from Croatian patients.|pdf=|usr=012}}
| |
| − | {{tp|p=32640417|t=2020. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.|pdf=|usr=012}}
| |
| − | {{tp|p=32610564|t=2020. COVID-19 as a Vascular Disease: Lesson Learned from Imaging and Blood Biomarkers.|pdf=|usr=012}}
| |
| − | {{tp|p=32646736|t=2020. Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms.|pdf=|usr=012}}
| |
| − | {{tp|p=32650275|t=2020. Reappearance of effector T cells is associated with recovery from COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32629393|t=2020. Illuminating COVID-19 lung disease through autopsy studies.|pdf=|usr=012}}
| |
| − | {{tp|p=32632419|t=2020. Eosinopenia and COVID-19 patients: So specific ?|pdf=|usr=012}}
| |
| − | {{tp|p=32633718|t=2020. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.|pdf=|usr=012}}
| |
| − | {{tp|p=32614767|t=2020. Main Routes of Entry and Genomic Diversity of SARS-CoV-2, Uganda.|pdf=|usr=012}}
| |
| − | {{tp|p=32618497|t=2020. High neutralizing antibody titer in intensive care unit patients with COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32620946|t=2020. Coronary artery dilatation in a child with hyperinflammatory syndrome with SARS-CoV-2-positive serology.|pdf=|usr=012}}
| |
| − | {{tp|p=32615182|t=2020. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32634438|t=2020. Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus.|pdf=|usr=012}}
| |
| − | {{tp|p=32631841|t=2020. JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk.|pdf=|usr=012}}
| |
| − | {{tp|p=32631838|t=2020. Rapid onset honeycombing fibrosis in spontaneously breathing patient with Covid-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32631836|t=2020. Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?|pdf=|usr=012}}
| |
| − | {{tp|p=32646049|t=2020. Mutation Patterns of Human SARS-CoV-2 and Bat RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions, Indicating Rapid Evolution in Their Hosts.|pdf=|usr=012}}
| |
| − | {{tp|p=32646047|t=2020. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.|pdf=|usr=012}}
| |
| − | {{tp|p=32645523|t=2020. Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses.|pdf=|usr=012}}
| |
| − | {{tp|p=32640274|t=2020. SARS-CoV2 envelope protein: Non-synonymous mutations and its consequences.|pdf=|usr=012}}
| |
| − | {{tp|p=32641873|t=2020. Inflammation, Immunity and Immunogenetics in COVID-19: A Narrative Review.|pdf=|usr=012}}
| |
| − | {{tp|p=32621172|t=2020. Multisystem Inflammatory Syndrome in Children in COVID-19 Pandemic.|pdf=|usr=012}}
| |
| − | {{tp|p=32615316|t=2020. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission.|pdf=|usr=012}}
| |
| − | {{tp|p=32622082|t=2020. Ancestral origin, antigenic resemblance and epidemiological insights of novel coronavirus (SARS-CoV-2): Global burden and Bangladesh perspective.|pdf=|usr=012}}
| |
| − | {{tp|p=32638151|t=2020. A viral infection explanation for Kawasaki disease in general and for COVID-19 virus-related Kawasaki disease symptoms.|pdf=|usr=012}}
| |
| − | {{tp|p=32634585|t=2020. Dynamic changes of peripheral blood lymphocytes subsets in adult patients with COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32613447|t=2020. SARS-CoV-2-related deaths in routine forensic autopsy practice: histopathological patterns.|pdf=|usr=012}}
| |
| − | {{tp|p=32630032|t=2020. Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity.|pdf=|usr=012}}
| |
| − | {{tp|p=32629995|t=2020. Putative Roles for Peptidylarginine Deiminases in COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32645951|t=2020. Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting.|pdf=|usr=012}}
| |
| − | {{tp|p=32640747|t=2020. Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications.|pdf=|usr=012}}
| |
| − | {{tp|p=32621017|t=2020. SARS-COV-2 and eye immunity: the lesson was learned but we are not done yet. Brainstorming on possible pathophysiology inspired by ocular models.|pdf=|usr=012}}
| |
| − | {{tp|p=32642784|t=2020. Serum antibody response in critically ill patients with COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32624257|t=2020. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.|pdf=|usr=012}}
| |
| − | {{tp|p=32615258|t=2020. Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak.|pdf=|usr=012}}
| |
| − | {{tp|p=32639084|t=2020. Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID-19/SARS-CoV-2.|pdf=|usr=012}}
| |
| − | {{tp|p=32634129|t=2020. Kinetics of viral load and antibody response in relation to COVID-19 severity.|pdf=|usr=012}}
| |
| − | {{tp|p=32610587|t=2020. Does SARS-CoV-2 Trigger Stress-InducedAutoimmunity by Molecular Mimicry? A Hypothesis.|pdf=|usr=012}}
| |
| − | {{tp|p=32635302|t=2020. Atherosclerosis as Pathogenetic Substrate for Sars-Cov2 Cytokine Storm.|pdf=|usr=012}}
| |
| − | {{tp|p=32645361|t=2020. Inflammasome Activation and Pyroptosis in Lymphopenic COVID-19 Liver Patients.|pdf=|usr=012}}
| |
| − | {{tp|p=32615199|t=2020. SARS-CoV-2 detection, viral load and infectivity over the course of an infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32622905|t=2020. Longitudinal anti-SARS-CoV-2 antibody profile and neutralization activity of a COVID-19 patient.|pdf=|usr=012}}
| |
| − | {{tp|p=32614392|t=2020. Clinical characteristics and factors associated with long-term viral excretion in patients with SARS-CoV-2 infection: a single center 28-day study.|pdf=|usr=012}}
| |
| − | {{tp|p=32647285|t=2020. Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents.|pdf=|usr=012}}
| |
| − | {{tp|p=32645344|t=2020. Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination.|pdf=|usr=012}}
| |
| − | {{tp|p=32645661|t=2020. Is the presence of lung injury in COVID-19 an independent risk factor for secondary lung cancer?|pdf=|usr=012}}
| |
| − | {{tp|p=32645660|t=2020. Is macrophages heterogeneity important in determining COVID-19 lethality?|pdf=|usr=012}}
| |
| − | {{tp|p=32650197|t=2020. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.|pdf=|usr=012}}
| |
| − | {{tp|p=32645659|t=2020. Epithelial cilia is the first line of defence against Coronavirus; addressing the observed age-gradient in the COVID-19 infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32646911|t=2020. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Early Manifestations of COVID-19 in Israel.|pdf=|usr=012}}
| |
| − | {{tp|p=32646908|t=2020. Coding-Complete Genome Sequence of SARS-CoV-2 Isolate from Bangladesh by Sanger Sequencing.|pdf=|usr=012}}
| |
| − | {{tp|p=32641700|t=2020. Immunological and inflammatory profiles in mild and severe cases of COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32641705|t=2020. Single cell transcriptome revealed SARS-CoV-2 entry genes enriched in colon tissues and associated with coronavirus infection and cytokine production.|pdf=|usr=012}}
| |
| − | {{tp|p=32648040|t=2020. Unlocking the lockdown of science and demystifying COVID-19: how autopsies contribute to our understanding of a deadly pandemic.|pdf=|usr=012}}
| |
| − | {{tp|p=32642842|t=2020. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists.|pdf=|usr=012}}
| |
| − | {{tp|p=32627524|t=2020. Considerations around the SARS-CoV-2 Spike Protein with particular attention to COVID-19 brain infection and neurological symptoms.|pdf=|usr=012}}
| |
| − | {{tp|p=32650002|t=2020. ASSOCIATION OF INITIAL VIRAL LOAD IN SARS-CoV-2 PATIENTS WITH OUTCOME AND SYMPTOMS.|pdf=|usr=012}}
| |
| − | {{tp|p=32631071|t=2020. COVID-ARDS Clarified: A Vascular Endotype?|pdf=|usr=012}}
| |
| − | {{tp|p=32649217|t=2020. RV Infections in Asthmatics Increase ACE2 Expression and Cytokine Pathways Implicated in COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32608999|t=2020. COVID-19 Severity Correlates with Weaker T Cell Immunity, Hypercytokinemia and Lung Epithelium Injury.|pdf=|usr=012}}
| |
| − | {{tp|p=32628534|t=2020. Clinical Validity of Serum Antibodies to SARS-CoV-2: A Case-Control Study.|pdf=|usr=012}}
| |
| − | {{tp|p=32633104|t=2020. Covid-19 related IgA vasculitis.|pdf=|usr=012}}
| |
| − | {{tp|p=32636189|t=2020. Covid-19: Herd immunity is "unethical and unachievable," say experts after report of 5% seroprevalence in Spain.|pdf=|usr=012}}
| |
| − | {{tp|p=32643798|t=2020. Tackling COVID-19 infection through complement-targeted immunotherapy.|pdf=|usr=012}}
| |
| − | {{tp|p=32640169|t=2020. Potential impact of SARS-CoV-2 infection on the thymus.|pdf=|usr=012}}
| |
| − | {{tp|p=32641195|t=2020. Reply to the letter concerning Kawasaki Disease and Covid-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32638018|t=2020. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart.|pdf=|usr=012}}
| |
| − | {{tp|p=32636454|t=2020. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques.|pdf=|usr=012}}
| |
| − | {{tp|p=32639942|t=2020. Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study.|pdf=|usr=012}}
| |
| − | {{tp|p=32639941|t=2020. The early antibody response to SARS-Cov-2 infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32638022|t=2020. Direct evidence of active SARS-CoV-2 replication in the intestine.|pdf=|usr=012}}
| |
| − | {{tp|p=32645713|t=2020. Microbiota and Covid-19. Which came first, the chicken or the egg?|pdf=|usr=012}}
| |
| − | {{tp|p=32645228|t=2020. Angiotensin II Receptors - Impact for COVID-19 Severity.|pdf=|usr=012}}
| |
| − | {{tp|p=32631463|t=2020. COVID-19: Yin and Yang and Herd Immunity.|pdf=|usr=012}}
| |
| − | {{tp|p=32645207|t=2020. Basic Immunology may lead to translational therapeutic rationale:: SARS-CoV-2 and Rheumatic Diseases.|pdf=|usr=012}}
| |
| − | {{tp|p=32635753|t=2020. Pathology and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).|pdf=|usr=012}}
| |
| − | {{tp|p=32614086|t=2020. Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies.|pdf=|usr=012}}
| |
| − | {{tp|p=32629518|t=2020. Inflammatory Cell Infiltration of Adrenals in COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32643416|t=2020. SARS-CoV-2 Receptor ACE2 is upregulated in Colonic Organoids from Hypertensive Rats.|pdf=|usr=012}}
| |
| − | {{tp|p=32615317|t=2020. Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models.|pdf=|usr=012}}
| |
| − | {{tp|p=32624498|t=2020. COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby.|pdf=|usr=012}}
| |
| − | {{tp|p=32643586|t=2020. On the potential role of exosomes in the COVID-19 reinfection/reactivation opportunity.|pdf=|usr=012}}
| |
| − | {{tp|p=32639183|t=2020. The Inter-alpha-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology.|pdf=|usr=012}}
| |
| − | {{tp|p=32640487|t=2020. BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy.|pdf=|usr=012}}
| |
| − | {{tp|p=32644266|t=2020. Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32644223|t=2020. Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32639581|t=2020. Changes in RT-PCR test results and symptoms during the menstrual cycle of female individuals infected with SARS-CoV-2: Report of two cases.|pdf=|usr=012}}
| |
| − | {{tp|p=32633840|t=2020. The variability of the serological response to SARS corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity).|pdf=|usr=012}}
| |
| − | {{tp|p=32633815|t=2020. An update on the origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and pangolin derived coronaviruses varied in the critical binding site and O-linked glycan residues.|pdf=|usr=012}}
| |
| − | {{tp|p=32642770|t=2020. Proteome-wide Data Analysis Reveals Tissue-specific Network Associated with SARS-CoV-2 Infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32640066|t=2020. Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran.|pdf=|usr=012}}
| |
| − | {{tp|p=32641486|t=2020. Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.|pdf=|usr=012}}
| |
| − | {{tp|p=32622377|t=2020. Kawasaki disease in the COVID-19 era: a distinct clinical phenotype?|pdf=|usr=012}}
| |
| − | {{tp|p=32611256|t=2020. Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32640127|t=2020. Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32641847|t=2020. A COVID-19 model.|pdf=|usr=012}}
| |
| − | {{tp|p=32647358|t=2020. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.|pdf=|usr=012}}
| |
| − | {{tp|p=32647346|t=2020. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects.|pdf=|usr=012}}
| |
| − | {{tp|p=32616673|t=2020. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.|pdf=|usr=012}}
| |
| − | {{tp|p=32638509|t=2020. The interface between coronaviruses and host cell RNA biology: Novel potential insights for future therapeutic intervention.|pdf=|usr=012}}
| |
| − |
| |
| − | {{tp|p=32611670|t=2020. Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in synovial tissues.|pdf=|usr=012}}
| |
| − | {{tp|p=32627126|t=2020. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?|pdf=|usr=012}}
| |
| − | {{tp|p=32641482|t=2020. LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.|pdf=|usr=012}}
| |
| − | {{tp|p=32622376|t=2020. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.|pdf=|usr=012}}
| |
| − | {{tp|p=32619412|t=2020. Endothelial cells orchestrate COVID-19 coagulopathy.|pdf=|usr=012}}
| |
| − | {{tp|p=32619411|t=2020. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study.|pdf=|usr=012}}
| |
| − | {{tp|p=32616514|t=2020. Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework.|pdf=|usr=012}}
| |
| − | {{tp|p=32629204|t=2020. A hypothesis on the role of the human immune system in covid-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32622045|t=2020. Integrated Approaches to Reveal Mechanisms by which RNA Viruses Reprogram the Cellular Environment.|pdf=|usr=012}}
| |
| − | {{tp|p=32616647|t=2020. Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Morocco.|pdf=|usr=012}}
| |
| − | {{tp|p=32616644|t=2020. Genome Sequencing of a Severe Acute Respiratory Syndrome Coronavirus 2 Isolate Obtained from a South African Patient with Coronavirus Disease 2019.|pdf=|usr=012}}
| |
| − | {{tp|p=32620916|t=2020. Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32632085|t=2020. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.|pdf=|usr=012}}
| |
| − | {{tp|p=32612128|t=2020. High-altitude populations need special considerations for COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32636479|t=2020. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns.|pdf=|usr=012}}
| |
| − | {{tp|p=32636475|t=2020. SARS-CoV-2-specific T cells without antibodies.|pdf=|usr=012}}
| |
| − | {{tp|p=32629960|t=2020. Evidence for SARS-CoV-2 Infection of Animal Hosts.|pdf=|usr=012}}
| |
| − | {{tp|p=32640525|t=2020. Molecular Aspects of COVID-19 Differential Pathogenesis.|pdf=|usr=012}}
| |
| − | {{tp|p=32627515|t=2020. Dysregulation of the immune system as a driver of the critical course of the novel coronavirus disease 2019.|pdf=|usr=012}}
| |
| − | {{tp|p=32638966|t=2020. Immunological aspects of coronavirus disease during pregnancy: an integrative review.|pdf=|usr=012}}
| |
| − | {{tp|p=32621057|t=2020. The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2.|pdf=|usr=012}}
| |
| − | {{tp|p=32616709|t=2020. Mapping the T cell response to COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32619819|t=2020. S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In Silico Study.|pdf=|usr=012}}
| |
| − | {{tp|p=32615987|t=2020. Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis.|pdf=|usr=012}}
| |
